In early December, Techcrunch Disrupt London came to town. The event hosts Startup Battlefield which gathers early stage startups together on one stage to compete for the Disrupt Cup and a cash prize. As expected, the agenda was jam-packed with a wide-range topics from Brexit and walking robot dogs to flying cars and the continued disruption and innovation of Fintech. On the VC front On the venture capital front, Niklas Zennström, Atomico said that early stage Seed and Series A investments in Europe are now on par with the US, both in terms of amount of capital invested and number of companies….
It’s highly likely that Brexit will affect the value of many UK businesses’ Intellectual Property Rights (IPR) portfolios. But in the Brexit era, JAG Shaw Baker’s Intellectual Property team put together ten insider tips for you to consider if you’re concerned about your IPR. You should always check with your lawyer to be sure your IPR are up-to-date with the most recent regulations. The Ultimate Brexit Intellectual Property Tip List Take a look at the extent to which your business relies on pan-EU IP rights. It’s important to consider EU rights such as EU trademarks and registered and unregistered community designs. Are these protected…
Congratulations to our client Doctify Limited on raising more than $1M in their Series A funding round led by Amadeus Capital. We advised Doctify from their inception and their initial seed funding through to their Series A funding. It’s been exciting to see their success from the start! Doctify is a new healthcare booking platform that gives patients a tool to search for specialist doctors, compare reviews and prices and book online appointments. In a January article in the Evening Standard, the company says it aims to become the go-to online health platform.
According to data from London & Partners, UK tech companies raised more than $2.1 billion in the first nine months of 2015. In January 2016, London & Partners released new data indicating that since 2010, UK technology companies have collectively raised almost $10 billion. Inc Magazine published an article about the 10 growing VC trends to look for in 2016. Among them was early and seed stage funding. Whether it’s via a crowd sourced platform, seed investor or super angel, the options for early stage capital isn’t slowing down. This type of funding increasingly takes the form of quick, efficient…
According to The Macro, the ecosystem for seed or early financing is far more complex now than it was just five years ago. From super angels or micro VCs to VC firms themselves with an emphasis on seed funding, the landscape has multiple layers inside the seed funding market. Even the size of seeds has changed. The average size of a seed round on the rise anywhere from €200,000 to €6 million (what we call a super-sized seed). There’s a lot of advice out there too. Philipp Moehring, Head of Europe for AngelList, has some tips for raising a seed round without…
We’re pleased to be advisors to InMotion, the independent venture from Jaguar Land Rover. InMotion plans to transform the experience of personal travel and deliver greater freedom, choice and well-being in movement. In other words, smart transportation. Smart Transportation Hackathon On November 3, 2016 in London, InMotion is having it’s first hackathon. The hackathon is focused on transforming the future of transportation. During the day, from 5:30 to 11:30 pm, hackers will have a chance to solve a technical challenge that can be utilised by the wider community. This gives them a chance to be a part of solving real customer mobility problems….
Looking back to our last post in the Ins and Outs series on Confidentiality, you’ll see there’s an obvious disconnect and therefore potential conflict in relation to publication rights between a sponsor and the principal investigator (PI)/institution. Onerous restrictions on publication rights could be counterproductive and unlikely to be accepted by the institution and PI. For a start, it could potentially sour the goodwill and alliance established between the institution, PI and sponsor prior to commencing the clinical trial. Further, sponsors understand that for many institutions and PIs, in addition to facilitating the development of new medicines, conducting clinical trials has the allure…
In Life Science news, Akarna Therapeutics Ltd. was acquired by Allergan plc (NYSE: AGN) for an upfront cash payment of $50 million. JAG Shaw Baker acted on behalf of New Science Ventures LLC, a New York venture capital fund that invests in novel scientific approaches. New Science Ventures was one of the selling shareholders alongside Third Point Ventures and Forbion Capital Partners. Akarna Therapeutics is a UK company with offices in Cambridge, UK and San Diego, California. Akarna Therapeutic’s lead product candidate (AKN-083) is considered an effective and novel treatment of non-alcoholic steatohepatitis (NASH) and other liver diseases. An M&A…
Anna Farmer joins the intellectual property (IP) team at JAG Shaw Baker from Maclay Murray & Spens LLP where she was a trainee solicitor for two years. Anna will focus on contentious and non-contentious IP matters. This includes trademark and patent matters as well as data protection, cyber-squatting, licensing, technology, copyright and database and design rights. On being a lawyer When talking about being an IP lawyer, Anna says the complexity of IP and technology today, intertwined with the types of clients JAG Shaw Baker works with, is what inspires her as a lawyer. Anna is a graduate of Durham University…
A new month brings new beginnings at JAG Shaw Baker and today we’re pleased to announce a new partner at the firm, Howard Watt. Howard comes to JAG Shaw Baker from Eight Roads (the private investment arm of Fidelity International) where he has been in-house Counsel for the past six years. While there, Howard advised Eight Roads’ European Venture Fund on investments including Innogames, Made.com, NotOnTheHighStreet, AppsFlyer and Wahanda (now Treatwell), including the latter’s $171 m exit to Recruit. As a partner on our corporate team, Howard’s background includes deal work in venture capital, private equity, private investment funds and…
Welcome to the JAG Shaw Baker blog. This is the place where we talk about clients, current news affecting the start-up community, trends in life sciences, digital technology and clean tech markets and even some opinions on legal matters affecting high-growth companies today. We welcome your comments!
Get in touch
If you would like any information on JAG Shaw Baker, please email our marketing department: email@example.com
A cookie is a small file of letters and numbers that we store on your browser or computer, phone or tablet hard drive if you agree. more information
A cookie is a small file of letters and numbers that we store on your browser or computer, phone or tablet hard drive if you agree.
We use the following cookies:
• Strictly necessary cookies. These are cookies that are required for the operation of our website. They include, for example, cookies that enable you to return to a previous page.
• Analytical/performance cookies. They allow us to recognise and count the number of visitors and to see how visitors move around our website when they are using it. This helps us to improve the way our website works, for example, by ensuring that users are finding what they are looking for easily. The analytical/performance cookies are provided on our behalf by Google Inc. to aid with reporting of user behaviour, market research and improving website functionality. This user behaviour is analysed in order to improve this website. To see how this applies to Google Analytics, visit http://www.google.co.uk/intl/en/analytics/privacyoverview.html. You can stop tracking by Google Analytics by visiting https://tools.google.com/dlpage/gaoptout?hl=en-GB.
The strictly necessary session cookies are a temporary cookie which remains in the cookie file of your browser until you close the browser. The other cookies will remain in the cookie file of your browser after the closing of the browser, and will become active again when you reopen this website. The different cookies have different expiration dates. Following expiry of a cookie, a new version of that cookie will be downloaded when you next visit this website, unless you have withdrawn your consent in the meantime.
You can block cookies by activating the setting on your browser that allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or parts of our website.